Creative Capital Management Investments’s Idexx Laboratories IDXX Stock Holding History

Creative Capital Management Investments’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.69K	Buy	+7	New	+$3.93K	﹤0.01%	535

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Creative Capital Management Investments's IDXX Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 7 shares worth $3.69K. The stake represents ﹤0.01% of the portfolio and ranks #535 among its holdings.

1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Creative Capital Management Investments held 7 shares of Idexx Laboratories worth $3.69K as of Q2 2026.
Idexx Laboratories was a new Creative Capital Management Investments position in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #535 holding.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.